Using the IP-MS approach, which has also been used to quantify the protein levels in the CSF, it was discovered that AD dementia and prodromal AD cases had significantly higher CSF levels of both synaptosomal-associated protein 25 (SNAP-25) and synaptotagmin-1 (SYT1) [101]. The gene discussed is SYT1; the disease is Alzheimer disease.